Dare Bioscience | 10-Q: Q2 2024 Earnings Report
Dare Bioscience | 8-K: Daré Bioscience Reports Second Quarter 2024 Financial Results and Provides Company Update Conference Call and Webcast Today at 4:30 p.m. ET
Dare Bioscience | 8-K: Current report
Dare Bioscience | 8-K: Current report
Dare Bioscience | 4: Statement of changes in beneficial ownership of securities-Director Matz Gregory W
Dare Bioscience | 4: Statement of changes in beneficial ownership of securities-Director Kelley Susan L.
Dare Bioscience | 4: Statement of changes in beneficial ownership of securities-Director RASTETTER WILLIAM H
Dare Bioscience | 4: Statement of changes in beneficial ownership of securities-Director Steele Robin Joan
Dare Bioscience | 4: Statement of changes in beneficial ownership of securities-Director Grossman Jessica D.
Dare Bioscience | 8-K: Current report
Dare Bioscience | 10-Q: Q1 2024 Earnings Report
Dare Bioscience | 8-K: Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated 2024 Milestones
Dare Bioscience | EFFECT: Others
Dare Bioscience | 424B5: Prospectus
Dare Bioscience | CORRESP: CORRESP
Dare Bioscience | EFFECT: Others
Dare Bioscience | 424B3: Prospectus
Dare Bioscience | 8-K: Current report
Dare Bioscience | CORRESP: CORRESP
Dare Bioscience | ARS: Annual Report to Security Holders
No Data
No Data